NCT02711709

Brief Summary

The purpose of this study is to define the natural history and causes of chronic critical illness (CCI) in surgical intensive care patients who have had sepsis. The investigator wants to study a sub-population of sepsis patients that have intra-abdominal sepsis. The purpose of this research study is to define the acute changes in frailty (weakness, slowness, loss of muscle mass), comorbidity (medical problems) and disability (difficulty with mobility and performing routine daily functions) after having an infection that is located in the abdominal cavity or torso. The investigator believes having severe infection contributes to acute and permanent changes in these areas, especially in those of advanced age.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
53

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2016

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 24, 2016

Completed
22 days until next milestone

First Posted

Study publicly available on registry

March 17, 2016

Completed
15 days until next milestone

Study Start

First participant enrolled

April 1, 2016

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 10, 2020

Completed
6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

February 11, 2026

Completed
Last Updated

April 16, 2026

Status Verified

April 1, 2026

Enrollment Period

3.9 years

First QC Date

February 24, 2016

Last Update Submit

April 13, 2026

Conditions

Keywords

Intra-abdominal sepsisSurgical ICU

Outcome Measures

Primary Outcomes (2)

  • A change in rate of participants (0-100%) that meet frailty consensus criteria comparing baseline score to assessments after (3, 6, 12 months) episode of intra-abdominal sepsis using the Fried Frailty Criteria.

    1\. Fried Frailty Criteria: Possible score of 0-5 based on clinical criteria. Score of 0 = "Not Frail", Score of 1-2 = "pre-frail", score ≥3 = "Frail". Integer score, no units of measures

    Baseline, 3, 6 and 12 months.

  • A change in rate of participants (0-100%) that meet frailty consensus criteria comparing baseline score to assessments after (3, 6, 12 months) episode of intra-abdominal sepsis using the Rockwood Frailty Criteria.

    Rockwood Frailty Criteria: Ratio (0-1.0) based on number of positive clinical factors of a 70 item list of clinical deficits (i.e. 7/70 deficits = 0.1). Ratio score, no units of measure.

    Baseline, 3, 6 and 12 months.

Secondary Outcomes (4)

  • Change in measurement of torso sarcopenia.

    Baseline, 3, 6 and 12 months.

  • A change in the Modified Minnesota leisure time activities questionnaire from baseline to the one year mark.

    Baseline, 3, 6 and 12 month

  • A change in mobility and activity from hospitalization to the one year mark.

    Baseline, 3, 6 and 12 months.

  • Mortality

    Up to one year

Study Arms (1)

Intra-abdominal sepsis

Frailty measurements. Modified Minnesota Leisure Time Activities. Computed tomography morphometrics. Mobility Monitors.

Other: Frailty MeasurementsOther: Modified Minnesota Leisure Time ActivitiesOther: Computed tomography morphometricsOther: Mobility Monitors

Interventions

A frailty index will be determined as a combination of factors. An older adult is considered physically vulnerable when they experience: 1. muscle weakness 2. fatigue 3. low physical activity, and unintentional loss in body weight, which has been agreed upon by a consensus of experts. This will be collected at baseline, 3, 6 and 12 months.

Intra-abdominal sepsis

A questionnaire used to assess physical activity will be administered at baseline, 3, 6 and 12 months.

Intra-abdominal sepsis

A CT scan will occur as standard of care while the patient is hospitalized. Two additional CT scans will occur at 3 and 12 months to assess for sarcopenia.

Intra-abdominal sepsis

Mobility monitors will be placed on the patients during the duration of their hospital stay. They will then where them at 3, 6 and 12 months for up to 10 days.

Intra-abdominal sepsis

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Intra-Abdominal Sepsis Patients

You may qualify if:

  • Admission to the surgery or trauma ICU where clinical care can be managed by surgical critical care guided by standard operating procedures.
  • Age ≥18 years
  • Diagnosis of sepsis, severe sepsis, or septic shock
  • Entrance into the standard-of-care sepsis protocol
  • Ability to obtain patient/legally authorized representative informed consent.

You may not qualify if:

  • Significant traumatic brain injury (evidence of neurologic injury on CT scan and a best Glascow Coma Scale \<8 within 24 hours of injury)
  • Refractory shock (i.e., patients who die within 12 hours)
  • Alternative or confounding diagnosis causing shock state (e.g., myocardial infarction or pulmonary embolus)
  • Uncontrollable source of sepsis (e.g., irreversible disease state such as unresectable dead bowel),
  • Patients deemed to be futile care or have advanced care directives limiting resuscitative efforts such as patient or patient's family who are not committed to aggressive management of the patient's condition. Expected lifespan of the patient is less than 3 months due to severe pre-existing comorbidities (ex. Recurrent, advanced or metastatic cancer).
  • Severe Congestive Heart Failure (NY Heart Association Class IV)
  • Child-Pugh Class C liver disease or pre-liver transplant.
  • Known HIV infection with CD4 count\<200 cells/mm3,
  • Organ transplant recipient on immunosuppressive agents
  • Known pregnancy
  • Inability to obtain informed consent
  • Prisoners
  • Institutionalized patients
  • Chemotherapy or radiotherapy within 30 days prior to sepsis
  • Spinal cord injuries resulting in permanent sensory and/or motor deficits.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UF Health at Shands hospital

Gainesville, Florida, 32610, United States

Location

MeSH Terms

Conditions

Sepsis

Condition Hierarchy (Ancestors)

InfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Philip Efron, MD

    University of Florida

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 24, 2016

First Posted

March 17, 2016

Study Start

April 1, 2016

Primary Completion

February 10, 2020

Study Completion

February 11, 2026

Last Updated

April 16, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations